Quantitative nucleic acid test for use on the cobas® 5800/6800/8800 Systems
The cobas® EBV test provides reliable, standardized, high-quality results for the improved management of transplant patients at risk of infection. The test is used by healthcare professionals to assess if transplant patients are at risk of developing disease caused by Epstein-Barr Virus (EBV). The test is for use on the automated cobas® 5800/6800/8800 Systems.
Epstein-Barr Virus (EBV) diseases, including EBV-associated post-transplant lymphoproliferative disorder (PTLD) remain important causes of morbidity and mortality in patients undergoing solid organ transplantation (SOT) and hematopoietic cell transplantation (HCT).1 Early detection with best-in-class monitoring tools provides actionable results which enable informed treatment decisions.
Reference